The current study included cases starting from 2001, while MGMT promotor methylation and IDH1 mutation statuses were first introduced to classify glioblastoma prognosis in 2005 (Hegi et al. 2005) and 2009 (Nobusawa et al. 2009), respectively. The gene discussed is IDH1; the disease is glioblastoma.